Latest News about Mpox
Recent news which mentions Mpox
UK Secures Additional Doses Of Bavarian Nordic Mpox Vaccine To Combat New Variant Threat
September 17, 2024
From Benzinga
Moderna's Investigational Mpox Vaccine More Effective Than Current Approved Shot, Animal Study Shows
September 06, 2024
From Benzinga
Mpox Vaccines: Challenges Persist as Congo Receives First Batch Of Doses Almost 2 Years After It Declared Epidemic
September 06, 2024
From Benzinga
Mpox Vaccine: Emergent BioSolutions' Smallpox Vaccine Gets FDA Nod For Expanded Use For Individuals At High Risk Of Mpox Infection
August 30, 2024
From Benzinga
EXCLUSIVE: Virax Biolabs Inks Distribution Pact For Mpox Diagnostic Kits In Europe And Middle East
August 28, 2024
From Benzinga
WHO Seeks $135M In Funding To Fight Mpox: Outbreak 'Can Be Controlled, And Can Be Stopped'
August 26, 2024
From Benzinga
Diagnostic Giants Labcorp, Roche To Ramp Up Testing Capacity Amid Global Concerns Over New Mpox Strain
August 26, 2024
From Benzinga
Tonix Pharma Collaborates With World's Largest Vaccine Manufacturer For Mpox Vaccine
August 26, 2024
From Benzinga
Why Is Diagnostic Tests Provider Applied DNA Sciences Stock Trading Higher On Friday?
August 23, 2024
From Benzinga
Virax Biolabs Announces Stock Offering: What To Know
August 22, 2024
From Benzinga
Snowflake, GeoVax, Zoom, Target, Tesla: Why These 5 Stocks Are On Investors' Radars Today
August 21, 2024
From Benzinga
GeoVax Labs Stock Surges Ahead Of The Close, Shares Remain Volatile: What's Happening?
August 21, 2024
From Benzinga
GeoVax Stock Is Tumbling Tuesday: What's Going On?
August 20, 2024
From Benzinga
Virax Biolabs Shares Climb With Mpox Cases: What To Know
August 19, 2024
From Benzinga
Mpox Vaccine Maker Bavarian Nordic Targets Broader Access With European Submission For Imvanex Adolescent Use During WHO Emergency
August 16, 2024
From Benzinga
Mpox Declared A Global Public Health Emergency By WHO Amid Rapid International Spread
August 14, 2024
Tickers
NEWS
From Benzinga